GenDx LLC

GenDx is a science-based molecular diagnostics company specializing in HLA typing and transplantation diagnostics. The company develops and markets pre- and post-transplant reagent kits, NGS-based HLA typing solutions, and proprietary laboratory software for clinical diagnostics. Product lines include NGSgo-AmpX (next-generation sequencing HLA typing kits for various gene targets including HLA-DRB1, DQB1, and DPB1) and complementary software platforms known for reliability, intuitive navigation, and rapid analysis. GenDx serves transplant laboratories, biobanks, and research institutions globally, with particular emphasis on user-friendly workflows and technical support. The company offers world-class customer support, educational events, and training programs for end users at all proficiency levels. GenDx appears to operate as part of a larger acquisition ecosystem, as evidenced by recent press releases regarding CareDx's transplant lab product division. The company maintains a strong focus on molecular diagnostics quality, laboratory efficiency, and continuous innovation in companion diagnostics and precision medicine applications.